デフォルト表紙
市場調査レポート
商品コード
1479065

医療画像解析ソフトウェア市場:ソフトウェアタイプ別、モダリティ別、画像タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2017年~2031年

Medical Image Analysis Software Market Assessment, By Software Type, By Modality, By Imaging Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 225 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
医療画像解析ソフトウェア市場:ソフトウェアタイプ別、モダリティ別、画像タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2017年~2031年
出版日: 2024年05月14日
発行: Market Xcel - Markets and Data
ページ情報: 英文 225 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医療画像解析ソフトウェアの市場規模は、予測期間の2024年~2031年のCAGRが7.6%になると予測され、2023年の36億7,000万米ドルから2031年には65億9,000万米ドルに成長するとみられています。医療画像解析ソフトウェアは、医用画像と診断市場の急成長に伴って需要が高まっています。ヘルスケア専門家、特に放射線医は、コンピュータベースの診断分析の可能性を認識しており、このようなソフトウェアの需要を押し上げています。

様々な診断モダリティによって生成された画像は、臨床調査のためにさらに分析される必要がありますが、人為的なミスや無知は時に誤った診断や不利な臨床結果につながることがあります。医療画像解析ソフトウェアとヘルスケア専門家の専門知識を組み合わせることで、最良の臨床結果が得られます。世界の疾病負担の増加により診断要件が増加し、世界の医療画像解析ソフトウェア市場の成長を牽引しています。ソフトウェアサービスや医療用画像診断機器における技術的進歩は、ソフトウェアアルゴリズムにおける人工知能や機械学習の統合とともに、市場の成長に大きく貢献しています。しかし、高度な機器やソフトウェアの高額な価格設定による購入資金の不足は、市場開発の大きな制約の1つとなっています。分析を処理し、適切な臨床結果を解釈する熟練した専門家の不足も、市場拡大の課題です。

当レポートでは、世界の医療画像解析ソフトウェア市場について調査し、市場の概要とともに、ソフトウェアタイプ別、モダリティ別、画像タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の医療画像解析ソフトウェア市場の見通し、2017年~2031年

  • 市場規模と予測
  • ソフトウェアタイプ別
  • モダリティ別
  • 画像タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別
  • 企業別市場シェア(%)、2023年

第5章 世界の医療画像解析ソフトウェア市場の見通し、地域別、2017年~2031年

  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

  • 需要供給分析
  • 輸出入分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

  • Koninklijke Philips N.V.
  • Agfa-Gevaert Group
  • Canon Medical Systems Corporation
  • Siemens Healthineers AG
  • Esaote SPA
  • Neusoft Corporation
  • GE HealthCare Technologies, Inc.
  • Siemens Healthcare Private Limited
  • Carestream Health, Inc.
  • ESAOTE SPA

第14章 戦略的提言

第15章 お問い合わせと免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 3.Global Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 4.Global Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 5.Global Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 6.Global Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Medical Image Analysis Software Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 9.North America Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 10.North America Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 11.North America Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 12.North America Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 13.North America Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Medical Image Analysis Software Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.United States Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 17.United States Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 18.United States Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 19.United States Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 20.United States Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 22.Canada Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 23.Canada Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 24.Canada Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 25.Canada Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 26.Canada Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 28.Mexico Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 29.Mexico Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 30.Mexico Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 31.Mexico Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 32.Mexico Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 34.Europe Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 35.Europe Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 36.Europe Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 37.Europe Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 38.Europe Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Medical Image Analysis Software Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.Germany Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 42.Germany Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 43.Germany Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 44.Germany Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 45.Germany Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.France Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 48.France Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 49.France Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 50.France Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 51.France Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Italy Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 54.Italy Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 55.Italy Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 56.Italy Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 57.Italy Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 59.United Kingdom Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 60.United Kingdom Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 61.United Kingdom Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 62.United Kingdom Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 63.United Kingdom Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Russia Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 66.Russia Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 67.Russia Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 68.Russia Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 69.Russia Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 71.Netherlands Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 72.Netherlands Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 73.Netherlands Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 74.Netherlands Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 75.Netherlands Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 77.Spain Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 78.Spain Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 79.Spain Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 80.Spain Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 81.Spain Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.Turkey Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 84.Turkey Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 85.Turkey Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 86.Turkey Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 87.Turkey Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Poland Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 90.Poland Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 91.Poland Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 92.Poland Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 93.Poland Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.South America Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 96.South America Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 97.South America Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 98.South America Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 99.South America Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Medical Image Analysis Software Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.Brazil Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 103.Brazil Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 104.Brazil Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 105.Brazil Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 106.Brazil Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 108.Argentina Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 109.Argentina Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 110.Argentina Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 111.Argentina Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 112.Argentina Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 114.Asia-Pacific Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 115.Asia-Pacific Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 116.Asia-Pacific Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 117.Asia-Pacific Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 118.Asia-Pacific Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Medical Image Analysis Software Market Share (%), By Country, 2017-2031F
  • Figure 120.India Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 121.India Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 122.India Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 123.India Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 124.India Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 125.India Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.China Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 128.China Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 129.China Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 130.China Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 131.China Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 133.Japan Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 134.Japan Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 135.Japan Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 136.Japan Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 137.Japan Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 139.Australia Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 140.Australia Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 141.Australia Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 142.Australia Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 143.Australia Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 145.Vietnam Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 146.Vietnam Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 147.Vietnam Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 148.Vietnam Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 149.Vietnam Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 151.South Korea Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 152.South Korea Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 153.South Korea Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 154.South Korea Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 155.South Korea Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 157.Indonesia Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 158.Indonesia Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 159.Indonesia Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 160.Indonesia Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 161.Indonesia Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 163.Philippines Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 164.Philippines Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 165.Philippines Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 166.Philippines Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 167.Philippines Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 169.Middle East & Africa Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 170.Middle East & Africa Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 171.Middle East & Africa Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 172.Middle East & Africa Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 173.Middle East & Africa Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Medical Image Analysis Software Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 176.Saudi Arabia Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 177.Saudi Arabia Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 178.Saudi Arabia Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 179.Saudi Arabia Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 180.Saudi Arabia Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.UAE Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 183.UAE Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 184.UAE Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 185.UAE Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 186.UAE Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Medical Image Analysis Software Market, By Value, In USD Billion, 2017-2031F
  • Figure 188.South Africa Medical Image Analysis Software Market Share (%), By Software Type, 2017-2031F
  • Figure 189.South Africa Medical Image Analysis Software Market Share (%), By Modality, 2017-2031F
  • Figure 190.South Africa Medical Image Analysis Software Market Share (%), By Imaging Type, 2017-2031F
  • Figure 191.South Africa Medical Image Analysis Software Market Share (%), By Application, 2017-2031F
  • Figure 192.South Africa Medical Image Analysis Software Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Software Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194.By Modality Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195.By Imaging Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 198.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX11316

Global medical image analysis software market is projected to witness a CAGR of 7.6% during the forecast period 2024-2031F, growing from USD 3.67 billion in 2023 to USD 6.59 billion in 2031F. Medical image analysis software is in high demand as the medical imaging and diagnostics market grows rapidly. Healthcare professionals, especially radiologists, are recognizing the potential of computer-based diagnostic analysis, driving a boost in the demand for such software.

The images generated by various diagnostics modalities need to be analyzed further for clinical investigation, human error or ignorance sometimes may lead to wrong diagnoses and adverse clinical outcomes. Medical image analysis software combined with the expertise of healthcare professionals brings out the best clinical outcomes. The growing global disease burden increases diagnostic requirements and subsequently drives the growth of the global medical image analysis software market. Technical advancements in software services and medical imaging devices along with the integration of artificial intelligence and machine learning in software algorithms have significantly helped in the growth of the market. However, lack of funds for sophisticated instrumentation and software purchase due to their high pricing is one of the major constraints for market development. Lack of skilled professionals to handle the analysis and interpret proper clinical outcomes is another challenge for the market expansion.

In May 2023, GE HealthCare announced US FDA 510(k) approval of Precision DL, a novel deep learning-based image processing software. It is included in the growing portfolio of GE HealthCare's Effortless Recon DL. Precision. This AI-based technology is integrated with the company's fastest-ever-selling PET/CT, Omni Legend. Omni Legend already enhances the sensitivity of prior digital scanners and impressive small lesion detectability, enabling faster scan times. The availability of both Omni Legend and Precision DL, marks third generation sensitivity era of PET/CT scans.

Growing Demand for Precision Diagnostics

The demand for diagnostic services and products is significantly rising under the influence of growing disease burden, rising geriatric population, growing demand for rapid diagnostics, and many more factors. The incidence and prevalence rate of chronic diseases have risen significantly in recent years marking the rise in medical imaging procedures being performed. The rising population of elders globally subsequently contributes to the higher number of medical imaging tests being performed. The rise in lifestyle-associated diseases further drives the market.

For instance, as per Diagnostic Imaging Dataset Statistical Release, published by NHS England in May 2023, around 43.4 million imaging tests were performed in England in a year between February 2022 to January 2023. Out of these, 3.41 million imaging tests were performed in January 2023, which constitutes Plain Radiography (X-ray-1.65 million), followed by Diagnostic Ultrasonography (0.81 million), Computerized Axial Tomography (CT Scan, 0.52 million), and Magnetic Resonance Imaging (MRI, 0.31 million).

Technical Advances in Medical Imaging

Medical imaging witnessed several advances in recent years such as advanced signal processing, sensor fusion, artificial intelligence, and deep learning, to enhance accuracy and precision in diagnoses. The image analysis software is being enabled to integrate AI and machine learning algorithms for better clinical investigations. The evolution in cloud-based software has enabled low-cost operation and extended the flexibility and reliability of medical image analysis software. Manufacturers are constantly evolving with innovative solutions to enhance market growth.

For instance, in March 2024, Radical Imaging LLC announced the launch of its new product, FlexView which is a professionally supported, cloud-based universal medical imaging viewer, based on Open Health Imaging Foundation framework. The software is of commercial grade and can be incorporated easily into any medical imaging system, providing the capabilities of viewing and analyzing for almost all type of medical image or workflow. The cloud-based feature enables the workflow from anywhere without the need of installing any software and up-front investment or IT support. Radical Imaging is collaborating with AWS HealthImaging, NVIDIA, and Medicai, to ensure FlexView to be the most versatile and highest-performing cloud-based medical imaging software in the market.

Dominance of Integrated Software Segment

The integrated software segment is anticipated to hold the dominant position in the market with the highest value share and CAGR. The integrated software is extensively preferred over standalone software due to its wide array of advantages which includes reduction in efforts of manual data entry, improved communication between instruments and operator, reduction in reliance over tech department for assistance, and several other reasons. As multiple systems require more data handling and updating, it can be minimized by using integrated software. It enhances the automation in workflow by avoiding separate handling of devices. Thus, service providers are actively innovating new software and a variety of integrations in medical imaging instruments.

Cardiology to Lead Amongst the Applications

The share of cardiology segment based on application, is anticipated to dominate the global medical image analysis software market during the assessment period. It is due to high incidence of cardiology disorders occurring these days, owing to improper food habits, smoking, and drinking, and congenital reasons. The leading market region, North America, has a very high prevalence rate of cardiac conditions, and market players are introducing various AI-enabled diagnostic solutions to predict and diagnose underlying causes of cardiac disease. For instance, in June 2023, GE HealthCare launched a novel technology that cuts MRI heart scans by up to 83%. GE HealthCare is handling the limitations of cardiac magnetic resonance imaging (MRI) testing through its novel deep learning-based product 'Sonic DL'. The proposed technology is expected to scan up to 12 times faster than currently available means of examinations.

Asia-Pacific to be the Fastest Growing Region

With the presence of fastest growing economies, Asia-Pacific is anticipated to grow at a very fast pace with highest CAGR during the forecast period, owing to higher rate of adoption for medical imaging and associated software along with AI integration. The growing awareness about the efficacy of these products and solutions further boosts their demand in the market. Developing healthcare infrastructure and diagnostics facilities and rising disposable income of individuals in the region are chief reasons for faster growth rate of the region.

For instance, in September 2023, Fujitsu Limited and iSurgery Co., Ltd. announced a field trial from October 2023 to March 2025 for their "bone health promotion project" under their collaboration with the Department of Orthopaedic Surgery at Jikei University School of Medicine. The initiative aims to assess the feasibility of utilizing chest radiographs for bone assessments and evaluate the impact on Fujitsu employees' health attitudes and behaviors. During the trial, the project team will employ iSurgery's AI medical device, and the Chest Bone Indicator, which is a medical image analysis software to analyze bone health from chest radiographs and communicate the examination results to Fujitsu Group employees. Recommendations for further evaluation by medical specialists will be made based on these assessments.

Future Market Scenario

The future of medical image analysis software market comes with advancements driven by artificial intelligence and deep learning algorithms. These technologies have significantly enhanced the accuracy and efficiency of medical image analysis, thus, enabling rapid and accurate detection of abnormalities across various imaging modalities such as MRI, PET, ultrasound, X-rays, CT scans, and more. AI-based diagnostic tools speed up the interpretation of complex images and enhance early disease detection, leading to better clinical outcomes. Deep learning models, particularly convolutional neural networks (CNNs), play a crucial role in automating and accurately analyzing intricate imaging data, revolutionizing medical image analysis. For instance, in April 2023, Medical artificial intelligence solution provider Vuno received the US patent for its AI-based medical image analysis technology which contains VUNO Med chest CT AI (VUNO Med -Lung CT AI and VUNO Med DeepBrain (VUNO Med-Deep Brain). The patent is approved under the title "method of assisting visualization of lesions in medical images and a device using them."

Key Players Landscape and Outlook

The medical image analysis software market includes some of the well-established global players and tons of local players and startups present in the market scenario to cater to the market needs. These firms are employing strategic product developments, collaborations, and other market tactics to expand their offerings and cater to the growing market needs.

In December 2023, AiOne Healthcare Technologies Ltd announced a strategic partnership with DeepTek.ai, which is a leading United States-based AI technology company. The collaboration aims to launch DeepTek's AI-powered medical imaging analysis software to the United Kingdom market, further, enhancing diagnostic accuracy and workflow for healthcare professionals. DeepTek.ai is a medical imaging AI company involved in the development of AI-powered solutions for radiologists. Augmento is DeepTek's flagship product, which is a US FDA Cleared AI-powered radiology orchestration platform. Augmento is capable of automating routine tasks, streamlining workflow, and providing real-time insights to radiologists. The platform has been proven to enhance diagnostic accuracy by up to 20% and reduce turnaround time by up to 50%.

In January 2024, GE HealthCare announced an agreement to acquire MIM Software. MIM Software is a global leader providing medical imaging analysis and artificial intelligence (AI) solutions for various practice of radiation oncology, diagnostic imaging, molecular radiotherapy, and urology at healthcare settings such as hospitals, specialty clinics, imaging centers, and research organizations. GE HealthCare aims to utilize MIM Software's imaging analytics and digital workflow capabilities to accelerate innovation and differentiate its solutions across various care areas for the benefit of patients and healthcare systems globally.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Medical Image Analysis Software Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1. By Value
  • 4.2.By Software Type
    • 4.2.1.Integrated Software
    • 4.2.2.Stand-alone Software
  • 4.3.By Modality
    • 4.3.1.Tomography
      • 4.3.1.1.Computed Tomography
      • 4.3.1.2.Magnetic Resonance Imaging
      • 4.3.1.3.Positron Emission Tomography
      • 4.3.1.4.Single-Photon Emission Tomography
    • 4.3.2.Ultrasound Imaging
      • 4.3.2.1.2D
      • 4.3.2.2.3D and 4D
      • 4.3.2.3.Doppler
    • 4.3.3.Radiographic Imaging
    • 4.3.4.Combined Modalities
      • 4.3.4.1.PET/MR
      • 4.3.4.2.SPECT/CT
      • 4.3.4.3.PET/MR
    • 4.3.5.Mammography
  • 4.4.By Imaging Type
    • 4.4.1.2D Imaging
    • 4.4.2.3D Imaging
    • 4.4.3.4D Imaging
  • 4.5.By Application
    • 4.5.1.Orthopedic
    • 4.5.2.Dental
    • 4.5.3.Neurology
    • 4.5.4.Cardiology
    • 4.5.5.Oncology
    • 4.5.6.Obstetrics and Gynecology
    • 4.5.7.Mammography
    • 4.5.8.Urology and Nephrology
  • 4.6.By End-user
    • 4.6.1.Hospitals
    • 4.6.2.Diagnostic Centers
    • 4.6.3.Ambulatory Surgical Centers
    • 4.6.4.Others
  • 4.7.By Region
    • 4.7.1.North America
    • 4.7.2.Europe
    • 4.7.3.Asia-Pacific
    • 4.7.4.South America
    • 4.7.5.Middle East and Africa
  • 4.8.By Company Market Share (%), 2023

5.Global Medical Image Analysis Software Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
    • 5.1.2.By Software Type
      • 5.1.2.1.Integrated Software
      • 5.1.2.2.Stand-alone Software
    • 5.1.3.By Modality
      • 5.1.3.1.Tomography
        • 5.1.3.1.1.Computed Tomography
        • 5.1.3.1.2.Magnetic Resonance Imaging
        • 5.1.3.1.3.Positron Emission Tomography
        • 5.1.3.1.4.Single-Photon Emission Tomography
      • 5.1.3.2.Ultrasound Imaging
        • 5.1.3.2.1.2D
        • 5.1.3.2.2.3D and 4D
        • 5.1.3.2.3.Doppler
      • 5.1.3.3.Radiographic Imaging
      • 5.1.3.4.Combined Modalities
        • 5.1.3.4.1.PET/MR
        • 5.1.3.4.2.SPECT/CT
        • 5.1.3.4.3.PET/MR
      • 5.1.3.5.Mammography
    • 5.1.4.By Imaging Type
      • 5.1.4.1.2D Imaging
      • 5.1.4.2.3D Imaging
      • 5.1.4.3.4D Imaging
    • 5.1.5.By Application
      • 5.1.5.1.Orthopedic
      • 5.1.5.2.Dental
      • 5.1.5.3.Neurology
      • 5.1.5.4.Cardiology
      • 5.1.5.5.Oncology
      • 5.1.5.6.Obstetrics and Gynecology
      • 5.1.5.7.Mammography
      • 5.1.5.8.Urology and Nephrology
    • 5.1.6.By End-user
      • 5.1.6.1.Hospitals
      • 5.1.6.2.Diagnostic Centers
      • 5.1.6.3.Ambulatory Surgical Centers
      • 5.1.6.4.Others
    • 5.1.7.United States*
      • 5.1.7.1.Market Size & Forecast
        • 5.1.7.1.1.By Value
      • 5.1.7.2.By Software Type
        • 5.1.7.2.1.Integrated Software
        • 5.1.7.2.2.Stand-alone Software
      • 5.1.7.3.By Modality
        • 5.1.7.3.1.Tomography
          • 5.1.7.3.1.1.Computed Tomography
          • 5.1.7.3.1.2.Magnetic Resonance Imaging
          • 5.1.7.3.1.3.Positron Emission Tomography
          • 5.1.7.3.1.4.Single-Photon Emission Tomography
        • 5.1.7.3.2.Ultrasound Imaging
          • 5.1.7.3.2.1.2D
          • 5.1.7.3.2.2.3D and 4D
          • 5.1.7.3.2.3.Doppler
        • 5.1.7.3.3.Radiographic Imaging
        • 5.1.7.3.4.Combined Modalities
          • 5.1.7.3.4.1.PET/MR
          • 5.1.7.3.4.2.SPECT/CT
          • 5.1.7.3.4.3.PET/MR
        • 5.1.7.3.5.Mammography
      • 5.1.7.4.By Imaging Type
        • 5.1.7.4.1.2D Imaging
        • 5.1.7.4.2.3D Imaging
        • 5.1.7.4.3.4D Imaging
      • 5.1.7.5.By Application
        • 5.1.7.5.1.Orthopedic
        • 5.1.7.5.2.Dental
        • 5.1.7.5.3.Neurology
        • 5.1.7.5.4.Cardiology
        • 5.1.7.5.5.Oncology
        • 5.1.7.5.6.Obstetrics and Gynecology
        • 5.1.7.5.7.Mammography
        • 5.1.7.5.8.Urology and Nephrology
      • 5.1.7.6.By End-user
        • 5.1.7.6.1.Hospitals
        • 5.1.7.6.2.Diagnostic Centers
        • 5.1.7.6.3.Ambulatory Surgical Centers
        • 5.1.7.6.4.Others
    • 5.1.8.Canada
    • 5.1.9.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Software Type
  • 6.2.By Modality
  • 6.3.By Imaging Type
  • 6.4.By Application
  • 6.5.By End-user
  • 6.6.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.4.7.Supplier Power
    • 7.4.8.Buyer Power
    • 7.4.9.Substitution Threat
    • 7.4.10.Threat from New Entrant
    • 7.4.11.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Patent Landscape
  • 9.3.Regulatory Approvals
  • 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Koninklijke Philips N.V.
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Agfa-Gevaert Group
  • 13.3.Canon Medical Systems Corporation
  • 13.4.Siemens Healthineers AG
  • 13.5.Esaote SPA
  • 13.6.Neusoft Corporation
  • 13.7.GE HealthCare Technologies, Inc.
  • 13.8.Siemens Healthcare Private Limited
  • 13.9.Carestream Health, Inc.
  • 13.10.ESAOTE SPA

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer